Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer is a research paper published in New England Journal of Medicine (2016). On theSindex it has a DataRank of 0.886. It has been cited 367 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.886
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U10 CA180850
NCI NIH HHS
Grant: U10 CA180822
NCI NIH HHS
Grant: UG1 CA189867
NCI NIH HHS
Grant: U10 CA101165
NCI NIH HHS
Grant: U10 CA180868
NCI NIH HHS
Grant: P30 CA006927
NCI NIH HHS
Grant: U10 CA037517
NCI NIH HHS
Grant: U10 CA180855
NCI NIH HHS
Grant: U10 CA027469
FWCI
61.19
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals